Ask AI
Public Law114th CongressHealth
S. 799Became Law

Protecting Our Infants Act of 2015

This bill became law

Filed
Comm.
Floor
Both
Law

What it doesSummary public law (Nov 25, 2015)

(This measure has not been amended since it was reported to the Senate on October 1, 2015. The summary of that version is repeated here.)

Protecting Our Infants Act of 2015

(Sec. 2) This bill requires the Department of Health and Human Services (HHS) to review its activities related to prenatal opioid use, including neonatal abstinence syndrome, and develop a strategy to address gaps in research and gaps and overlap in programs. (An opioid is a drug with effects similar to opium, such as heroin or certain pain medications. Neonatal abstinence syndrome is withdrawal in a newborn.)

(Sec. 3) HHS must conduct a study and develop recommendations for preventing and treating prenatal opioid use disorders, including the effects of those disorders on infants. HHS must publish a report that includes:

  • an assessment of existing research on neonatal abstinence syndrome;
  • an evaluation of the causes, and barriers to treatment, of opioid use disorders among women of reproductive age and recommendations on preventing opioid use disorders in these women;
  • an evaluation of, and recommendations on, treatment for pregnant women with opioid use disorders and the effects of prenatal opioid use on infants; and
  • an evaluation of the differences in prenatal opioid use between demographic groups and recommendations on reducing disparities.
(Sec. 4) HHS may continue providing technical assistance: (1) to states and Indian tribes to improve neonatal abstinence syndrome surveillance; and (2) to states to support implementation of effective public health measures, such as disseminating information to educate the public on prenatal opioid use and neonatal abstinence syndrome.

What just happenedNov 25, 2015

Became Public Law No: 114-91.

Who’s behind it

Sen. McConnell, Mitch [R-KY](R-KY)Sponsor
22 cosponsors9 D12 R1 I
Read on Congress.gov
22cosponsors1committees23actions1related bills11subjects
  1. Nov 25, 2015President

    Became Public Law No: 114-91.

  2. Nov 25, 2015BecameLaw36000

    Became Public Law No: 114-91.

  3. Nov 25, 2015President

    Signed by President.

  4. Nov 25, 2015BecameLaw36000

    Signed by President.

  5. Nov 19, 2015Floor

    Presented to President.

  6. Nov 19, 2015President28000

    Presented to President.

  7. Nov 16, 2015FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  8. Nov 16, 2015FloorH37300

    On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H8180)

  9. Nov 16, 2015Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H8180)

  10. Nov 16, 2015FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on S. 799.

  11. Nov 16, 2015FloorH30000

    Considered under suspension of the rules. (consideration: CR H8180-8182)

  12. Nov 16, 2015FloorH30300

    Mr. Pitts moved to suspend the rules and pass the bill.

  13. Oct 22, 2015FloorH15000

    Held at the desk.

  14. Oct 22, 2015FloorH14000

    Received in the House.

  15. Oct 22, 2015Floor

    Message on Senate action sent to the House.

  16. Oct 22, 2015Floor

    Passed Senate with an amendment and an amendment to the Title by Unanimous Consent. (consideration: CR S7439-7441; text as passed Senate: CR S7439-7440)

  17. Oct 22, 2015Floor17000

    Passed/agreed to in Senate: Passed Senate with an amendment and an amendment to the Title by Unanimous Consent.(consideration: CR S7439-7441; text as passed Senate: CR S7439-7440)

  18. Oct 1, 2015Calendars

    Placed on Senate Legislative Calendar under General Orders. Calendar No. 246.

  19. Oct 1, 2015Committee

    Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute and an amendment to the title. Without written report.

    Health, Education, Labor, and Pensions Committee
  20. Oct 1, 2015Committee14000

    Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute and an amendment to the title. Without written report.

    Health, Education, Labor, and Pensions Committee
  21. Sep 30, 2015Committee

    Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

    Health, Education, Labor, and Pensions Committee
  22. Mar 19, 2015IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1662; text of measure as introduced: CR S1662-1663)

    Health, Education, Labor, and Pensions Committee
  23. Mar 19, 2015IntroReferral10000

    Introduced in Senate

Public LawNov 25, 201549

(This measure has not been amended since it was reported to the Senate on October 1, 2015. The summary of that version is repeated here.)

Protecting Our Infants Act of 2015

(Sec. 2) This bill requires the Department of Health and Human Services (HHS) to review its activities related to prenatal opioid use, including neonatal abstinence syndrome, and develop a strategy to address gaps in research and gaps and overlap in programs. (An opioid is a drug with effects similar to opium, such as heroin or certain pain medications. Neonatal abstinence syndrome is withdrawal in a newborn.)

(Sec. 3) HHS must conduct a study and develop recommendations for preventing and treating prenatal opioid use disorders, including the effects of those disorders on infants. HHS must publish a report that includes:

  • an assessment of existing research on neonatal abstinence syndrome;
  • an evaluation of the causes, and barriers to treatment, of opioid use disorders among women of reproductive age and recommendations on preventing opioid use disorders in these women;
  • an evaluation of, and recommendations on, treatment for pregnant women with opioid use disorders and the effects of prenatal opioid use on infants; and
  • an evaluation of the differences in prenatal opioid use between demographic groups and recommendations on reducing disparities.
(Sec. 4) HHS may continue providing technical assistance: (1) to states and Indian tribes to improve neonatal abstinence syndrome surveillance; and (2) to states to support implementation of effective public health measures, such as disseminating information to educate the public on prenatal opioid use and neonatal abstinence syndrome.
Passed House without amendmentNov 16, 201581

(This measure has not been amended since it was reported to the Senate on October 1, 2015. The summary of that version is repeated here.)

Protecting Our Infants Act of 2015

(Sec. 2) This bill requires the Department of Health and Human Services (HHS) to review its activities related to prenatal opioid use, including neonatal abstinence syndrome, and develop a strategy to address gaps in research and gaps and overlap in programs. (An opioid is a drug with effects similar to opium, such as heroin or certain pain medications. Neonatal abstinence syndrome is withdrawal in a newborn.)

(Sec. 3) HHS must conduct a study and develop recommendations for preventing and treating prenatal opioid use disorders, including the effects of those disorders on infants. HHS must publish a report that includes:

  • an assessment of existing research on neonatal abstinence syndrome;
  • an evaluation of the causes, and barriers to treatment, of opioid use disorders among women of reproductive age and recommendations on preventing opioid use disorders in these women;
  • an evaluation of, and recommendations on, treatment for pregnant women with opioid use disorders and the effects of prenatal opioid use on infants; and
  • an evaluation of the differences in prenatal opioid use between demographic groups and recommendations on reducing disparities.
(Sec. 4) HHS may continue providing technical assistance: (1) to states and Indian tribes to improve neonatal abstinence syndrome surveillance; and (2) to states to support implementation of effective public health measures, such as disseminating information to educate the public on prenatal opioid use and neonatal abstinence syndrome.
Passed Senate amendedOct 22, 201535

(This measure has not been amended since it was reported to the Senate on October 1, 2015. The summary of that version is repeated here.)

Protecting Our Infants Act of 2015

(Sec. 2) This bill requires the Department of Health and Human Services (HHS) to review its activities related to prenatal opioid use, including neonatal abstinence syndrome, and develop a strategy to address gaps in research and gaps and overlap in programs. (An opioid is a drug with effects similar to opium, such as heroin or certain pain medications. Neonatal abstinence syndrome is withdrawal in a newborn.)

(Sec. 3) HHS must conduct a study and develop recommendations for preventing and treating prenatal opioid use disorders, including the effects of those disorders on infants. HHS must publish a report that includes:

  • an assessment of existing research on neonatal abstinence syndrome;
  • an evaluation of the causes, and barriers to treatment, of opioid use disorders among women of reproductive age and recommendations on preventing opioid use disorders in these women;
  • an evaluation of, and recommendations on, treatment for pregnant women with opioid use disorders and the effects of prenatal opioid use on infants; and
  • an evaluation of the differences in prenatal opioid use between demographic groups and recommendations on reducing disparities.
(Sec. 4) HHS may continue providing technical assistance: (1) to states and Indian tribes to improve neonatal abstinence syndrome surveillance; and (2) to states to support implementation of effective public health measures, such as disseminating information to educate the public on prenatal opioid use and neonatal abstinence syndrome.
Reported to Senate with amendment(s)Oct 1, 20151

Protecting Our Infants Act of 2015

(Sec. 2) This bill requires the Department of Health and Human Services (HHS) to review its activities related to prenatal opioid use, including neonatal abstinence syndrome, and develop a strategy to address gaps in research and gaps and overlap in programs. (An opioid is a drug with effects similar to opium, such as heroin or certain pain medications. Neonatal abstinence syndrome is withdrawal in a newborn.)

(Sec. 3) HHS must conduct a study and develop recommendations for preventing and treating prenatal opioid use disorders, including the effects of those disorders on infants. HHS must publish a report that includes:

  • an assessment of existing research on neonatal abstinence syndrome;
  • an evaluation of the causes, and barriers to treatment, of opioid use disorders among women of reproductive age and recommendations on preventing opioid use disorders in these women;
  • an evaluation of, and recommendations on, treatment for pregnant women with opioid use disorders and the effects of prenatal opioid use on infants; and
  • an evaluation of the differences in prenatal opioid use between demographic groups and recommendations on reducing disparities.
(Sec. 4) HHS may continue providing technical assistance: (1) to states and Indian tribes to improve neonatal abstinence syndrome surveillance; and (2) to states to support implementation of effective public health measures, such as disseminating information to educate the public on prenatal opioid use and neonatal abstinence syndrome.
Introduced in SenateMar 19, 2015

Protecting Our Infants Act of 2015

This bill requires the Agency for Healthcare Research and Quality to report on prenatal opioid abuse and neonatal abstinence syndrome (symptoms of withdrawal in a newborn). (An opioid is a drug with effects similar to opium, such as heroin or certain pain medications.) The report must include:

  • an assessment of existing research on neonatal abstinence syndrome;
  • an evaluation of the causes, and barriers to treatment, of opioid use disorders among women of reproductive age;
  • an evaluation of treatment for pregnant women with opioid use disorders and infants with neonatal abstinence syndrome; and
  • recommendations on preventing, identifying, and treating opioid dependency in women and neonatal abstinence syndrome.

The Department of Health and Human Services must review its activities related to prenatal opioid use and neonatal abstinence syndrome and develop a strategy to address gaps in research and programs.

The Centers for Disease Control and Prevention must provide technical assistance to states to improve neonatal abstinence syndrome surveillance and make surveillance data publicly available.
Protecting Our Infants Act of 2015 — Informed